卡巴多
卡巴多 性质
熔点 | 239-240°C |
---|---|
沸点 | 405.47°C (rough estimate) |
密度 | 1.3602 (rough estimate) |
折射率 | 1.6000 (estimate) |
闪点 | 18°(64°F) |
储存条件 | 2-8°C |
溶解度 | DMSO(轻微超声处理) |
形态 | 粉末 |
酸度系数(pKa) | 10.51±0.46(Predicted) |
颜色 | 黄色至深黄色 |
水溶解性 | Soluble in 1N NaOH (50 mg/ml), and water (partly). |
稳定性 | 感光 |
CAS 数据库 | 6804-07-5 |
EPA化学物质信息 | Hydrazinecarboxylic acid, 2-[(1,4-dioxido-2-quinoxalinyl)methylene]-, methyl ester (6804-07-5) |
卡巴多 用途与合成方法
Bacterial
The results of MTT assay demonstrate a dose-dependent decrease in mitochondrial activity in Vero cells at all concentrations of Carbadox. Treatment with Carbadox at the highest concentration of 160 μg/mL results in cell viability down to only 12%. Cells following Carbadox treatment show a dose-dependent increase of the DNA migration (p<0.01). The nuclear division index (NDI) reduces markedly with the increase doses of Carbadox.
Alpha diversities (Shannon diversity, Heips evenness, and inverse Simpson indices) of samples from medicated piglets compare to non-medicated piglets are significantly different at 2, 3, and 4 days after continuous Carbadox, but not different in either late Carbadox or at any time during the withdrawal period. Analysis of the community structure of bacteria in animals shows significant differences at days 3 and 4 of early Carbadox treatment ([R=0.32, p=0.015] and [R=0.54, p=0.003], respectively), but not before starting antibiotic treatment (p=0.82). No significant differences in E. coli colony forming units (CFUs) are observed during the Carbadox-treatment period of the study or late in the withdrawal period. E. coli CFUs are significantly different between the medicated and non-medicated groups on day 2 after the withdrawal of Carbadox.
安全信息
危险品标志 | F,T |
---|---|
危险类别码 | 45-11-22 |
安全说明 | 53-45 |
危险品运输编号 | UN 1325 4.1/PG 2 |
WGK Germany | 3 |
RTECS号 | FE2779000 |
危险等级 | 4.1 |
海关编码 | 29339900 |
毒害物质数据 | 6804-07-5(Hazardous Substances Data) |
卡巴多 价格(试剂级)
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024-11-08 | HY-B1340 | 卡巴多 | 6804-07-5 | 100mg | 400 |
2024-11-08 | HY-B1340 | 卡巴多 | 6804-07-5 | 10mM * 1mLin DMSO | 440 |